カイノスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/11/14 | 1,074 | 1,074 | 1,035 | 1,054 | -20 | -1.9% | 12,100 |
2023/11/13 | 1,101 | 1,101 | 1,057 | 1,074 | -20 | -1.8% | 18,300 |
2023/11/10 | 1,050 | 1,100 | 1,050 | 1,094 | +49 | +4.7% | 45,900 |
2023/11/09 | 1,036 | 1,048 | 1,035 | 1,045 | +13 | +1.3% | 5,400 |
2023/11/08 | 1,039 | 1,040 | 1,032 | 1,032 | -9 | -0.9% | 2,500 |
2023/11/07 | 1,037 | 1,045 | 1,037 | 1,041 | -4 | -0.4% | 3,700 |
2023/11/06 | 1,042 | 1,063 | 1,042 | 1,045 | +5 | +0.5% | 7,500 |
2023/11/02 | 1,033 | 1,049 | 1,033 | 1,040 | +7 | +0.7% | 6,200 |
2023/11/01 | 1,028 | 1,035 | 1,024 | 1,033 | +7 | +0.7% | 10,400 |
2023/10/31 | 1,022 | 1,027 | 1,022 | 1,026 | +3 | +0.3% | 1,200 |
2023/10/30 | 1,027 | 1,032 | 1,023 | 1,023 | -3 | -0.3% | 2,100 |
2023/10/27 | 1,024 | 1,030 | 1,024 | 1,026 | +1 | +0.1% | 1,600 |
2023/10/26 | 1,032 | 1,034 | 1,022 | 1,025 | ±0 | ±0% | 3,900 |
2023/10/25 | 1,020 | 1,070 | 1,020 | 1,025 | +5 | +0.5% | 36,100 |
2023/10/24 | 1,013 | 1,020 | 1,005 | 1,020 | +9 | +0.9% | 6,800 |
2023/10/23 | 1,014 | 1,017 | 1,010 | 1,011 | -4 | -0.4% | 5,300 |
2023/10/20 | 1,016 | 1,019 | 1,013 | 1,015 | -1 | -0.1% | 13,000 |
2023/10/19 | 1,015 | 1,020 | 1,012 | 1,016 | -2 | -0.2% | 7,600 |
2023/10/18 | 1,018 | 1,020 | 1,011 | 1,018 | ±0 | ±0% | 8,500 |
2023/10/17 | 1,026 | 1,026 | 1,018 | 1,018 | +1 | +0.1% | 5,700 |
2023/10/16 | 1,023 | 1,027 | 1,017 | 1,017 | -10 | -1% | 6,800 |
2023/10/13 | 1,028 | 1,029 | 1,024 | 1,027 | -2 | -0.2% | 6,300 |
2023/10/12 | 1,033 | 1,033 | 1,029 | 1,029 | -4 | -0.4% | 3,200 |
2023/10/11 | 1,031 | 1,037 | 1,030 | 1,033 | +2 | +0.2% | 6,600 |
2023/10/10 | 1,033 | 1,036 | 1,030 | 1,031 | +1 | +0.1% | 8,300 |
2023/10/06 | 1,034 | 1,037 | 1,030 | 1,030 | +1 | +0.1% | 3,500 |
2023/10/05 | 1,030 | 1,034 | 1,026 | 1,029 | +3 | +0.3% | 11,800 |
2023/10/04 | 1,033 | 1,039 | 1,023 | 1,026 | -12 | -1.2% | 9,000 |
2023/10/03 | 1,039 | 1,043 | 1,038 | 1,038 | -4 | -0.4% | 1,700 |
2023/10/02 | 1,045 | 1,053 | 1,041 | 1,042 | -3 | -0.3% | 3,200 |
2023/09/29 | 1,044 | 1,047 | 1,038 | 1,045 | +1 | +0.1% | 4,200 |
2023/09/28 | 1,048 | 1,050 | 1,030 | 1,044 | -4 | -0.4% | 2,800 |
2023/09/27 | 1,050 | 1,050 | 1,044 | 1,048 | +2 | +0.2% | 3,100 |
2023/09/26 | 1,054 | 1,054 | 1,044 | 1,046 | -8 | -0.8% | 3,100 |
2023/09/25 | 1,051 | 1,054 | 1,045 | 1,054 | +10 | +1% | 6,000 |
2023/09/22 | 1,047 | 1,048 | 1,043 | 1,044 | +1 | +0.1% | 3,600 |
2023/09/21 | 1,043 | 1,048 | 1,042 | 1,043 | ±0 | ±0% | 3,700 |
2023/09/20 | 1,053 | 1,053 | 1,043 | 1,043 | -6 | -0.6% | 2,300 |
2023/09/19 | 1,039 | 1,049 | 1,039 | 1,049 | +11 | +1.1% | 2,500 |
2023/09/15 | 1,044 | 1,046 | 1,036 | 1,038 | -1 | -0.1% | 14,100 |
2023/09/14 | 1,036 | 1,044 | 1,036 | 1,039 | +3 | +0.3% | 4,500 |
2023/09/13 | 1,041 | 1,044 | 1,036 | 1,036 | -3 | -0.3% | 5,500 |
2023/09/12 | 1,040 | 1,042 | 1,039 | 1,039 | -1 | -0.1% | 2,000 |
2023/09/11 | 1,048 | 1,048 | 1,040 | 1,040 | -2 | -0.2% | 2,200 |
2023/09/08 | 1,040 | 1,043 | 1,036 | 1,042 | +2 | +0.2% | 1,100 |
2023/09/07 | 1,046 | 1,048 | 1,032 | 1,040 | -6 | -0.6% | 8,300 |
2023/09/06 | 1,041 | 1,052 | 1,041 | 1,046 | +5 | +0.5% | 2,200 |
2023/09/05 | 1,040 | 1,047 | 1,040 | 1,041 | +1 | +0.1% | 1,100 |
2023/09/04 | 1,056 | 1,058 | 1,038 | 1,040 | -11 | -1% | 4,200 |
2023/09/01 | 1,034 | 1,051 | 1,034 | 1,051 | +16 | +1.5% | 6,300 |
251~
300
件表示中 / 3585件
類似銘柄と比較する
現在ご覧いただいている「カイノス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
カイノス | 120,000円 | +6.8% | -13.8% | 2.67% | 9.20倍 | 0.78倍 |
|
臨床検査薬の中堅メーカー。生化学、免疫血清学的検査用試薬に重点。共同開発の促進に注力 |
VIS | 90,100円 | +87.8% | +265.7% | 0.00% | 54.11倍 | 2.48倍 |
|
mRNA標的低分子創薬技術を製薬会社に提供。共同創薬研究などによる契約金収入が柱 |
クリングル | 85,500円 | +240.0% | - | 0.00% | - | 2.78倍 |
|
細胞の増殖、保護、修復などの機能があるHGFタンパク質を用いて、難治性疾患治療薬を開発 |
キッズバイオ | 12,100円 | - | - | 0.00% | - | 6.37倍 |
|
北大発創薬ベンチャー。バイオ後続品を主力に、乳歯歯髄幹細胞(SHED)用いた再生医療に力 |
DELTA-P | 52,500円 | - | - | 0.00% | - | 15.07倍 |
|
創薬ベンチャー。既存の抗がん物質を組み合わせて安全性と有効性を高めた抗がん剤を開発 |
市場注目の銘柄
チャート関連のコラム